China
3 articles on China, written by Shotlee and medically reviewed for clinical accuracy.
Mounjaro by Eli Lilly Included in China's National Health Coverage for Diabetes
Mounjaro, a drug by Eli Lilly, is set to be added to China's state health insurance on January 1st. This inclusion could intensify competition among pharmaceutical companies. The move aims to improve access for China's large population.
1 min read
Mounjaro by Eli Lilly Approved for China's State Insurance Coverage for Diabetes
Mounjaro, a drug by Eli Lilly, is set to be included in China's state-run health insurance program for individuals with type 2 diabetes starting January 1. This inclusion aims to improve access to the medication, although increased sales may be balanced by reduced prices. The drug was introduced in China earlier this year.
2 min read
Chinese Pharmaceutical Sector on the Verge of Global Expansion
China's pharmaceutical industry is rapidly ascending on the global stage, fueled by innovation and strategic alliances with Western companies. This rise presents both opportunities and challenges as China aims to become a major player in drug discovery and development.
7 min read